A clinical care pathway for managing pregnancy in patients with inflammatory arthritis. [PDF]
Amiri N +4 more
europepmc +1 more source
The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks' gestation. [PDF]
Touval O +5 more
europepmc +1 more source
Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: <i>A randomised clinical trial</i>. [PDF]
Fikry Yousef M +10 more
europepmc +1 more source
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. [PDF]
Chong E +17 more
europepmc +1 more source
Comparative analysis of social issues toward medical abortion using mifepristone in South Korea and the United States: Topic modeling and sentiment analysis. [PDF]
Ko M, Park DY, Oh JM, Song YK.
europepmc +1 more source
Abortion Restrictions Threaten Miscarriage Management In The United States. [PDF]
Nobles J, Hwang S, Bennett E, Jacques L.
europepmc +1 more source
Cancer metastasis chemoprevention prevents circulating tumour cells from germination. [PDF]
Xie X, Li Y, Lian S, Lu Y, Jia L.
europepmc +1 more source
Second-Trimester Induction Abortion Using Two Pretreatment Mifepristone Regimens: A Randomized Controlled Trial. [PDF]
Rajaraman V +4 more
europepmc +1 more source
Therapeutic Potential of Latin American Medicinal Plants in Oral Diseases: From Dental Pain to Periodontal Inflammation-A Systematic Review. [PDF]
Ramírez-Torres V +4 more
europepmc +1 more source
Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information Act. [PDF]
Cirucci CA, Aultman KA, Harrison DJ.
europepmc +1 more source

